DJIA 17,550.69 -47.51 -0.27%
NASDAQ 5,105.55 -9.84 -0.19%
S&P 500 2,093.32 -4.72 -0.22%
market minute promo

112.52 -0.71 (-0.63%)

Quote as of


company name or ticker

Recent Quotes

GWPH $112.52 -0.63%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $112.48
Previous Close $113.23
Daily Range $110.51 - $113.23
52-Week Range $58.16 - $133.98
Market Cap $2.2B
P/E Ratio -188.72
Dividend (Yield) $0.00 (0.0%)
Volume 274,022
Average Daily Volume 303,690
Current FY EPS -$3.46

Sector

Industry

GW Pharmaceuticals Plc (ADR) (GWPH) Description

GW Pharmaceuticals Plc - American Depositary Shares Website: http://www.gwpharm.com/

News & Commentary Rss Feed

Tougher Marijuana Regulations Could Be Coming to a State Near You

A new report from the CDC signals that tougher labeling requirements for marijuana edibles may be around the corner.

How will GW Pharmaceuticals (GWPH) Fare in Q3 Earnings? - Analyst Blog

The Key to Healing Broken Bones May Be Found in This Illegal Drug

Forget traditional medicines. According to researchers in Israel, this illegal drug may be the key to healing broken bones and preventing osteoporosis.

Will it trade high? Cannabis biotech Zynerba Pharmaceuticals sets terms for $42 million IPO

Midyear Report Card: Grading My Biotech Predictions for 2015

One Foolish investor shines a bright light on his biotech stocks predictions for this year.

Here's Why Marijuana Probably Won't Be Legalized by the Federal Government Before 2020

If you think marijuana legalization is around the corner, then this will probably change your tune.

3 Marijuana Stocks to Watch

There are lots of marijuana stocks to avoid, but these 3 merit investors' attention.

This Is a Big Win for Marijuana and Researchers

The Department of Health and Human Services just made a major change to the drug development process for marijuana-based therapies.

European ADRs Advance as Prospect of Greek Bailout Boosts Investor Confidence

Uncovering the cannabis cure: Zynerba Pharmaceuticals files for a $58 million IPO

See More GWPH News...